Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
This two-part article explores the new joint infringement standard set forth in the Federal Circuit's 2015 Akamai v. Limelight decision, 797 F.3d 1020, 1023 (Fed. Cir. 2015). Part 1 deconstructed the new standard and identified several ways in which courts could interpret and apply it. Part 2 reviews the recent Federal Circuit Eli Lilly case as well as district court cases that have interpreted the new standard and identifies prosecution and litigation strategies for practicing post-Akamai.
Eli Lilly v. Teva
The first district court case to meaningfully applying the new “conditions” standard was Eli Lilly & Co. v. Teva Parenteral Medicines, Inc., 126 F. Supp. 3d 1037 (S.D. Ind. 2015). In that case, Teva's generic premetrexed proposed label instructed physicians to tell patients to start taking folic acid one week before administering a premetrexed treatment. Id. at 1039. The folic acid pre-treatment was important for preventing life-threatening complications caused by premetrexed's toxicity. Id. at 1042. Eli Lilly's patent covered a method of treatment comprising administering folic acid prior to treating with premetrexed. Id. at 1039. Under the pre-Akamai “control or direction” test, a patient's acts would not have been attributable to a physician because the patient was not under the physician's control as part of an agency or contractual relationship. See, id. at 1042. The question for the court was whether a patient's self-administration of folic acid as instructed by a physician would be attributable to the physician under the new “conditions” standard. Id.
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
Defining commercial real estate asset class is essentially a property explaining how it identifies — not necessarily what its original intention was or what others think it ought to be. This article discusses, from a general issue-spot and contextual analysis perspective, how lawyers ought to think about specialized leasing formats and the regulatory backdrops that may inform what the documentation needs to contain for compliance purposes.
As courts and discovery experts debate whether hyperlinked content should be treated the same as traditional attachments, legal practitioners are grappling with the technical and legal complexities of collecting, analyzing and reviewing these documents in real-world cases.
How to Convey Your Merits In a Way That Earns Trust, Clients and Distinctions Just as no two individuals have the exact same face, no two lawyers practice in their respective fields or serve clients in the exact same way. Think of this as a "Unique Value Proposition." Internal consideration about what you uniquely bring to your clients, colleagues, firm and industry can provide untold benefits for your law practice.
The ever-evolving digital marketing landscape, coupled with the industry-wide adoption of programmatic advertising, poses a significant threat to the effectiveness and integrity of digital advertising campaigns. This article explores various risks to digital advertising from pixel stuffing and ad stacking to domain spoofing and bots. It will also explore what should be done to ensure ad fraud protection and improve effectiveness.
This article offers practical insights and best practices to navigate the path from roadmap to rainmaking, ensuring your business development efforts are not just sporadic bursts of activity, but an integrated part of your daily success.